Discovery and biological evaluation of proteolysis targeting chimeras (PROTACs) as an EGFR degraders based on osimertinib and lenalidomide

出版年份 2020 全文链接

标题

作者

关键词

Proteolysis targeting chimera, CRBN, EGFR-TK degrader, Osimertinib, Lenalidomide

出版物

Volume 30, Issue 12, Pages 127167

出版商

Elsevier BV

发表日期

2020-04-04

DOI

10.1016/j.bmcl.2020.127167

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started